Clinical Trial Update: A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease. [Phase 2]

View source ↗

Summary

Phase 2 trial results for KDT-3594 in early Parkinson's disease have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• KDT-3594

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED